ITMI20091109A1 - Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione - Google Patents

Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione

Info

Publication number
ITMI20091109A1
ITMI20091109A1 IT001109A ITMI20091109A ITMI20091109A1 IT MI20091109 A1 ITMI20091109 A1 IT MI20091109A1 IT 001109 A IT001109 A IT 001109A IT MI20091109 A ITMI20091109 A IT MI20091109A IT MI20091109 A1 ITMI20091109 A1 IT MI20091109A1
Authority
IT
Italy
Prior art keywords
polymorpho
preparation
methods
bazedoxifene acetate
bazedoxifene
Prior art date
Application number
IT001109A
Other languages
English (en)
Italian (it)
Inventor
Paolo Andreella
Franco Brazzarola
Roberto Brescello
Nicola Catozzi
Livius Cotarca
Paolo Fornasari
Mauro Maffini
Ivan Michieletto
Andrea Nicoli
Massimo Verzini
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Priority to IT001109A priority Critical patent/ITMI20091109A1/it
Priority to JP2010141370A priority patent/JP2011037832A/ja
Priority to CA2766618A priority patent/CA2766618A1/en
Priority to TW099120246A priority patent/TW201102378A/zh
Priority to PCT/US2010/039488 priority patent/WO2010151541A1/en
Priority to EP10728533A priority patent/EP2445876A1/en
Priority to US12/820,593 priority patent/US8063041B2/en
Priority to ARP100102214A priority patent/AR077203A1/es
Publication of ITMI20091109A1 publication Critical patent/ITMI20091109A1/it
Priority to JP2015237242A priority patent/JP2016033165A/ja
Priority to JP2017100527A priority patent/JP2017137360A/ja
Priority to JP2018142063A priority patent/JP2018162327A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IT001109A 2009-06-23 2009-06-23 Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione ITMI20091109A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT001109A ITMI20091109A1 (it) 2009-06-23 2009-06-23 Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
EP10728533A EP2445876A1 (en) 2009-06-23 2010-06-22 Polymorphic form d of bazedoxifene acetate and methods of preparing same
CA2766618A CA2766618A1 (en) 2009-06-23 2010-06-22 Polymorphic form d of bazedoxifene acetate and methods of preparing same
TW099120246A TW201102378A (en) 2009-06-23 2010-06-22 Polymorphic form D of bazedoxifene acetate and methods of preparing same
PCT/US2010/039488 WO2010151541A1 (en) 2009-06-23 2010-06-22 Polymorphic form d of bazedoxifene acetate and methods of preparing same
JP2010141370A JP2011037832A (ja) 2009-06-23 2010-06-22 酢酸バゼドキシフェンの多形フォームｄ及びその製造方法
US12/820,593 US8063041B2 (en) 2009-06-23 2010-06-22 Polymorphic Form D of bazedoxifene acetate and methods of preparing same
ARP100102214A AR077203A1 (es) 2009-06-23 2010-06-23 Forma polimorfica d del acetato de bazedoxifeno, composiciones farmaceuticas que la contienen metodo para prepararla y uso del mismo para tratar enfermedades mediadas por moduladores selectivos de receptores estrogenicos (serms)
JP2015237242A JP2016033165A (ja) 2009-06-23 2015-12-04 酢酸バゼドキシフェンの多形フォームｄ及びその製造方法
JP2017100527A JP2017137360A (ja) 2009-06-23 2017-05-22 酢酸バゼドキシフェンの多形フォームｄ及びその製造方法
JP2018142063A JP2018162327A (ja) 2009-06-23 2018-07-30 酢酸バゼドキシフェンの多形フォームｄ及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001109A ITMI20091109A1 (it) 2009-06-23 2009-06-23 Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione

Publications (1)

Publication Number Publication Date
ITMI20091109A1 true ITMI20091109A1 (it) 2010-12-24

Family

ID=42035899

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001109A ITMI20091109A1 (it) 2009-06-23 2009-06-23 Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione

Country Status (8)

Country Link
US (1) US8063041B2 (enExample)
EP (1) EP2445876A1 (enExample)
JP (4) JP2011037832A (enExample)
AR (1) AR077203A1 (enExample)
CA (1) CA2766618A1 (enExample)
IT (1) ITMI20091109A1 (enExample)
TW (1) TW201102378A (enExample)
WO (1) WO2010151541A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101597665B1 (ko) 2007-08-13 2016-02-24 몬산토 테크놀로지 엘엘씨 선충류 방제용 조성물 및 방법
WO2012037187A2 (en) * 2010-09-14 2012-03-22 Dr. Reddy's Laboratories Ltd. Preparation of crystalline bazedoxifene and its salts
WO2013182169A1 (en) 2012-06-07 2013-12-12 Zentiva, K. S. Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate
WO2013182170A1 (en) 2012-06-07 2013-12-12 Zentiva, K. S. Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
UA118254C2 (uk) 2012-12-04 2018-12-26 Монсанто Текнолоджи Ллс Нематоцидні водні композиції концентрату суспензії
CN103864664A (zh) * 2012-12-18 2014-06-18 江苏柯菲平医药有限公司 巴多昔芬乙酸盐新晶型及其制备方法
CN103864665B (zh) * 2014-03-04 2016-03-02 苏州特瑞药业有限公司 醋酸巴多昔芬的制备方法
CN104370796B (zh) * 2014-11-21 2016-09-14 扬子江药业集团有限公司 一种醋酸巴多昔芬多晶型b的制备方法
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
JP6863547B2 (ja) 2015-06-18 2021-04-21 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
KR20190096462A (ko) 2018-01-08 2019-08-20 (주)휴온스 바제독시펜 아세테이트 결정형 d형을 포함하는 안정성이 증가된 약제학적 조성물 및 그 제조방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN109851547B (zh) * 2018-12-27 2020-09-08 北京鑫开元医药科技有限公司 一种醋酸巴多昔芬晶型d的制备方法及用途
KR20190132311A (ko) 2019-11-15 2019-11-27 (주)휴온스 바제독시펜 아세테이트 결정형 d형을 포함하는 안정성이 증가된 약제학적 조성물 및 그 제조방법
CN111004165A (zh) * 2019-12-03 2020-04-14 南京正济医药研究有限公司 一种醋酸巴多昔芬晶型a的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US11246874B1 (en) 2021-04-20 2022-02-15 Oxygen Biotech LLC Treatment of COVID-19
CN113244240A (zh) * 2021-05-26 2021-08-13 深圳市人民医院 醋酸巴多昔芬在治疗急性髓系白血病药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
WO2005100316A1 (en) * 2004-04-07 2005-10-27 Wyeth Crystalline polymorph of a bazedoxifene acetate
WO2005100314A1 (en) * 2004-04-07 2005-10-27 Wyeth Crystalline polymorph of bazedoxifene acetate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772508A (en) 1954-04-28 1956-12-04 Claude A Greenlee Fish line pullaway sinker
EP0802183B1 (en) 1996-04-19 2001-10-10 American Home Products Corporation Estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US20040063692A1 (en) 2002-06-13 2004-04-01 Wyeth Bazedoxifene treatment regimens
US20050227966A1 (en) * 2004-04-08 2005-10-13 Wyeth Bazedoxifene acetate formulations
EP1919456A2 (en) 2005-08-24 2008-05-14 Wyeth a Corporation of the State of Delaware Bazedoxifene acetate formulations and manufacturing process thereof
CZ302358B6 (cs) * 2007-07-25 2011-03-30 Zentiva, A. S. Nové soli bazedoxifenu

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
WO2005100316A1 (en) * 2004-04-07 2005-10-27 Wyeth Crystalline polymorph of a bazedoxifene acetate
WO2005100314A1 (en) * 2004-04-07 2005-10-27 Wyeth Crystalline polymorph of bazedoxifene acetate

Also Published As

Publication number Publication date
JP2011037832A (ja) 2011-02-24
US20110021504A1 (en) 2011-01-27
WO2010151541A1 (en) 2010-12-29
JP2017137360A (ja) 2017-08-10
JP2016033165A (ja) 2016-03-10
WO2010151541A8 (en) 2011-05-12
EP2445876A1 (en) 2012-05-02
AR077203A1 (es) 2011-08-10
JP2018162327A (ja) 2018-10-18
TW201102378A (en) 2011-01-16
US8063041B2 (en) 2011-11-22
CA2766618A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
ITMI20091109A1 (it) Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
IL280133A (en) Methods and devices for the synthesis of nucleic acids
HUE040119T2 (hu) Orálisan alkalmazott kortikoszteroid készítmények
PT2413924T (pt) Fenil acetato de l-ornitina e métodos de preparação do mesmo
IL257290A (en) Antibodies to il 6 and their use
EP2548605A4 (en) Introducer assembly
EP2504031A4 (en) ANTI-IL-6 ANTIBODIES AND THEIR USE
BRPI1012004A2 (pt) "forma farmacêutica"
GB201006340D0 (en) Synthesis method and intermediates
IL230439A0 (en) Genes and proteins for the synthesis of alkanoyl-coenzyme - a
HUE058971T2 (hu) RSV F fehérjekészítmények és eljárások azok elõállítására
SI3222272T1 (sl) Farmacevtski pripravek karbetocina
ZA201107555B (en) Anti-17f antibodies and methods of use thereof
HUE037674T2 (hu) Eljárás uliprisztál-acetát és intermedierjének elõállítására
IL226106A0 (en) Methods and preparations for immunotherapy in neurological diseases
EP2593797A4 (en) NOVEL PROCESS FOR THE EVOLUTION OF PROTEINS
CR20130380A (es) Tableta dispensable en forma oral
EP2408473A4 (en) seeding method
SI2346850T1 (sl) Postopek za pripravo dabigatrana in njegovih intermediatov
BRPI0922653A2 (pt) preparação farmacêutica
BR112012031102A2 (pt) forma de dosagem oral sólida
DK2554059T3 (da) Oralt tobaksmateriale
IT1395633B1 (it) Filtro per motori endotermici
EP2721047A4 (en) PROCESSES FOR SYNTHESIS AND PURIFICATION OF DEOXYCHOLIC ACID
DK2335644T3 (da) Oral rensedel